Press release
Rhabdomyosarcoma Therapeutics Analysis 2018 by Key Players Roche, Epizyme, Novartis
RMS is a rare and malignant type of tumor which can arise from skeletal muscles, tendons, or connective tissues. The pathophysiology of this type of cancer is still unknown, but when it arises from the skeletal muscles, it can spread to any part of the body. RMS majorly arises from skeletal muscles, but the reason behind this remains unknown. RMS is the most common soft tissue tumor that occurs during childhood and accounts for approximately half of all soft tissue sarcomas in this age group.
Download report sample at: https://www.psmarketresearch.com/market-analysis/rms-therapeutics-pipeline-analysis/report-sample
*Advancement in Technology to Support RMS Therapeutics Pipeline Growth
Most of the companies are developing drug candidates using advanced technologies, and these drug candidates have showed positive efficacy in the clinical stage of development. For instance, Iproteos SL is developing its drug candidate using IPROTech technology platform which involves a combination of in-silico and in-vitro techniques. The technology encompasses state-of-the-art of various scientific fields, such as computational chemistry, modern organic synthesis, peptide chemistry, and experimental validation of potency, absorption, distribution, metabolism, and excretion (ADME) and permeability properties.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=rms-therapeutics-pipeline-analysis
Some of the key players involved in the development of RMS therapeutics include F. Hoffmann-La Roche Ltd., Epizyme Inc. and Novartis AG.
*RMS Therapeutics Pipeline is Witnessing Significant Growth due to Development of Combination Therapies
Several companies are developing combination therapies for the treatment of RMS, as these therapies are cost-effective and improve medication compliance by reducing burden of pills. For instance, (Dasatinib + Ganitumab) is a combination therapy under the Phase II stage of development by Bristol-Myers Squibb Company for the treatment of RMS. The drug candidate is a combination of small molecule (dasatinib) and monoclonal antibody (ganitumab), obtained from synthetic and natural source, respectively. It acts as Bcr-abl tyrosine kinase inhibitor and EphA2 receptor antagonist (dasatinib); and insulin-like growth factor-I receptor antagonist (ganitumab).
Browse report at: https://www.psmarketresearch.com/market-analysis/rms-therapeutics-pipeline-analysis
Combination therapies help to reduce frequency of dose administration, increase synergistic effect, and increase the potency of drugs for the treatment of RMS, thus driving the growth in pipeline.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rhabdomyosarcoma Therapeutics Analysis 2018 by Key Players Roche, Epizyme, Novartis here
News-ID: 1411671 • Views: …
More Releases from P&S Intelligence
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media.
In order to pace up the 4th industrial revolution, businesses across various industries…
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG.
North America will grow the fastest with a rate of 10.5% in…
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use.
Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls…
North America, the Largest Revenue Producer in Public Safety and Security Market
The size of the public safety and security market was at $411 billion in the year 2021, which will reach over $1,115 billion by the year 2030, advancing at a growth rate of around 12% in the years to come. This is largely ascribed to the rising application of innovative technologies in smart cities, increasing crime rates, the increasing cases of disastrous accidents, and the growing count of terrorist activities…
More Releases for RMS
RF Power Detector Market Report 2018: Segmentation by Type (Non-RMS power detect …
Global RF Power Detector market research report provides company profile for Analog Devices, Maxim Integrated, Texas Instruments, Intersil, Skyworks Solutions, Advanced Microwave, Broadcom, BroadWave Technologies, Clear Microwave and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to…
Advancement in Technology to Support the Growth in RMS Therapeutics Pipeline
RMS is a rare and malignant type of tumor which can arise from skeletal muscles, tendons, or connective tissues. The pathophysiology of this type of cancer is still unknown, but when it arises from the skeletal muscles, it can spread to any part of the body. RMS majorly arises from skeletal muscles, but the reason behind this remains unknown. RMS is the most common soft tissue tumor that occurs during…
RMS AUTOMOTIVE, MAZDA MOTORS UK FEIERN 10 JAHRE PARTNERSCHAFT
Das langfristige Engagement für das Remarketing von Innovation und Führung setzte einen Meilenstein
ATLANTA, 6. Juni 2017 – MS Automotive und Mazda Motors UK stellen die enorme Kraft einer langfristigen Zusammenarbeit unter Beweis und feiern dieses Jahr ihre zehnjährige Partnerschaft voller erfolgs- und leistungsorientierter Ergebnisse. RMS Automotive hat Mazda in dieser Zeit dabei geholfen, mehr als 14.500 Fahrzeuge zu verkaufen und mehr als 75 Prozent des Mazda Händlernetzwerks mithilfe…
RMS AUTOMOTIVE & MAZDA MOTORS UK FÊTENT LEURS 10 ANS DE PARTENARIAT
Un anniversaire important marqué par la priorité donnée sur le long terme au remarketing, à l'innovation et au leadership
ATLANTA, 6 juin 2017 – Illustrant à merveille la puissance extraordinaire d'une collaboration sur le long terme, RMS Automotive et Mazda Motors UK célèbrent cette année leurs 10 années de coopération, marquées par l'innovation et des résultats dynamisés par les performances.Au cours de cette décennie et grâce à sa solution de…
Global EMG Equipment Consumption Market 2017 : Haishen, RMS, Medcom, EGI & SYMTO …
The survey report by Market Research Store is an overview of the global EMG Equipment Consumption market. It covers all the recent trends including key developments in the global market in present and in future. Analyses of the global EMG Equipment Consumption market trends along with the projections of CAGRs (compound annual growth rates) are provided in the research report.
Further, an evaluation of the history of the global market and…
Retail Realm Announces New Release of Microsoft RMS Utilities Software
Global software distribution company continues to extend retail management functionality.
Sonoma, CA (June 13, 2011): Retail Realm (www.rrdisti.com.), a global software development and distribution company, has just released the latest version of their Utility Add-Ons that enhance and extend the industry-leading Microsoft Dynamics Retail Management System (RMS) software. Version 15 of RR RMS Utilities will give retailers the ability to utilize gift loyalty options, configure and send eReceipts, recall…
